Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer

Radiotherapy and Oncology

Volumn 102, Issue 3, 2012, Pages 412-415

  Borut, Kragelj ^a   Lijana, Zaletel Kragelj ^b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bladder cancer; Gemcitabine; Radiochemotherapy

Indexed keywords

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD TOXICITY; BONE MARROW DISEASE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DYSURIA; ENTEROPATHY; FATIGUE; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; LEUKOPENIA; LIVER TOXICITY; MALE; MULTIPLE CYCLE TREATMENT; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RECTUM HEMORRHAGE; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; URINARY FREQUENCY; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 84857924779     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.026     Document Type: Article

References (33)

1. B. Chauvet, Y. Brewer, C. Felix-Faure, J.L. Davin, C. Chouquent, and F. Reboul Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy J Urol 156 1996 1258 1262 (Pubitemid 26307589)
2. J.L. Lagrange, C. Bascoul-Mollevi, and L. Geoffrois Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015) Int J Radiat Oncol Biol Phys 79 2011 172 178
3. C. Weiss, D.G. Engehausen, F.S. Krause, T. Papadopoulos, J. Dunst, and R. Sauer Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer Int J Radiat Oncol Biol Phys 68 2007 1072 1080 (Pubitemid 47048579)
4. B. Kragelj, L. Zaletel-Kragelj, B. Sedmak, T. Čufer, and J. Červek Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer Radiother Oncol 75 2005 44 47 (Pubitemid 40616793)
5. V.K. Sangar, R. Cowan, G.P. Margison, J.H. Hendry, and N.W. Clarke An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines Br J Cancer 90 2004 542 548 (Pubitemid 38250656)
6. D.S. Schewach, and T.S. Lawrence Radiosenzitation of human solid tumor cell lines with gemcitabin Semin Oncol 23 1996 65 71 (Pubitemid 26362198)
7. D.S. Schewach, T.M. Hahn, E. Chang, L.W. Hertel, and T.S. Lawrence Metabolism of 2′,2′-difluoro-2-deoxycitidine and radiation sensitation of human colon carcinoma cells Cancer Res 54 1994 3218 3223
8. M. Joschko, L.K. Webster, and J. Groves Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model Radiat Oncol Investig 5 1997 62 71 (Pubitemid 27323505)
9. B. Pauwels, A.E.C. Korst, and G.O.G. Pattyn Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro Int J Radiat Oncol Biol Phys 57 2003 1075 1083 (Pubitemid 37324126)
10. J.W.G. van Putten, A. Price, A.H.D. van der Leest, A. Gregor, F.A. Little, and A. Groen JM Locally advanced non-small cell lung cancer Clin Cancer Res 9 2003 2472 2477
11. L. Trodella, P. Granone, and S. Valente Phase I trial of weekly gemcitabine and concurrent radiotherapy with inoperable non-small-cell lung cancer J Clin Oncol 20 2002 804 810 (Pubitemid 34111389)
12. M. Ikeda, S. Okada, K. Tokuuye, H. Ueno, and T. Okusaka A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer Br J Cancer 86 2002 1551 1554 (Pubitemid 34628107)
13. J.L. Aguillar-Ponce, M. Granados-Garcia, and V. Villavicencio Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck Ann Oncol 15 2004 301 306 (Pubitemid 38262632)
14. Lawrence TS, Eisbruch A, Scheach D. Gemcitabine-mediated radiosenzitation. Semin Oncol 1997, 24(Suppl 7):S7-24-S7-28.
15. K.A. Mason, L. Milas, and N.R. Hunter Maximazing therapeutic gain with gemcitabine and fractionated radiation Int J Radiat Oncol Biol Phys 44 1999 1125 1135 (Pubitemid 29342915)
16. P. Pattaranutaporn, Y.C. Thirapakawong, S. Therasakvichya, N. Ieumwananontachai, and K. Thephamongkhol Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma Gynecol Oncol 81 2001 404 407 (Pubitemid 32494654)
17. J.L. Abbruzzese, R. Grunewald, and E.A. Weeks A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J Clin Oncol 9 1991 491 498
18. D.D. von Hoff, J. Kuhn, and G.M. Clarke Design and conduct of phase I trials M.E. Buyse, M.J. Staquet, R.J. Sylvester, Cancer clinical trials, Methods and practice 1988 Oxford University Press Oxford
19. L.P. Muren, R. Smaaland, and O. Dahl Conformal radiotherapy of urinary bladder cancer Radiother Oncol. 73 2004 387 398 (Pubitemid 39601090)
20. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
21. A. Horwich, D. Dearnaley, and R. Huddart A randomised trial of accelerated radiotherapy for localised invasive bladder cancer Radiother Oncol 75 2005 34 43 (Pubitemid 40616792)
22. R.A. Cowan, C.A. McBain, and W.D. Ryder Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy Int J Radiat Oncol Biol Phys 59 2004 197 207 (Pubitemid 38501525)
23. W. Tester, A. Porter, and S. Asbell Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12 Int J Radiat Oncol Biol Phys 25 1993 783 790 (Pubitemid 23123381)
24. M.H.A. Hussain, T.R. Glass, and J. Forman Combination cisplatin, 5-fluorouracil and radiation for locally advanced unresectable or medically unfit bladder cancer cases: a southwest oncology group study J Urol 165 2001 56 61
25. D.S. Kaufman, K.A. Winter, and W.U. Shipley The initial results in muscle invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response Oncologist 5 2000 471 476
26. E. Kent, H. Sandler, and J. Montie Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation startegy: results of a phase I trial J Clin Oncol 22 2004 2540 2545 (Pubitemid 41103741)
27. V.K. Sangar, C.A. Mc Bain, and J. Lyons Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer Int J Radiat Oncol Biol Phys 61 2005 420 425 (Pubitemid 40164436)
28. O. Caffo, G. Fellini, and U. Graffer Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer Int J Radiat Oncol Biol Phys 57 2003 1310 1316 (Pubitemid 37443970)
29. A.S. Syed, T.N. Ansari, A. Mahmood, and I. Hussein Role of gemcitabine as radiation sensitizer in stage II&III carcinoma urinary bladder Proc Am Soc Clin Oncol 22 2004 4714
30. W. Tester, R. Caplan, and J. Hearney Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II trial 8802 J Clin Oncol 14 1996 119 126 (Pubitemid 26020004)
31. S. Tolan, V. Kong, and T. Rosewall Patient specific PTV margins in radiotherapy for bladder cancer-a feasibility study using cone beam CT Radiother Oncol 99 2011 34 43
32. F. Pos, A. Bex, and H.M. Dees-Ribbers Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer Radiother Oncol 93 2009 364 367
33. L. Tuomikoski, J. Collan, and J. Keyriliainen Adaptive radiotherapy in muscle invasive urinary bladder cancer. An effective method to reduce the irradiated bowel volume Radiother Oncol 99 2011 61 66